Quick update: Results are in from the PET/CT scan taken Oct 8, and indications are that everything is basically stable. Comparison of this month’s images with the scans from the beginning of the clinical trial (about a month ago) showed no new masses, and the sizes of the existing tumors look substantially the same. There seems to be activity, which could be good (immune system working) or bad (cancer cells growing). For now, we’re leaning toward good because just prior to the trial things were headed in the wrong direction and now they are just chillin’.
Next step is a scan on Nov 5 to see if the immuno-army can turn the tide and make some headway.